In research news:

A review of randomized clinical trials found that various cannabinoid compounds did not improve nausea, vomiting, or appetite, and only slightly improved chronic pain and spasticity in patients with long-term illnesses. The study, published in the Journal of the American Medical Association, found the greatest reductions in chronic pain were reported by patients who smoked tetrahydrocannabinol (THC) in eight of the trials, but the majority of the 79 trials in the meta-analysis demonstrated cannabinoids had little effect on HIV/AIDS patients with low-appetite and actually worsened chemotherapy-related nausea and vomiting. In total, the meta-analysis included 79 studies and 6,462 participants.

Read further details from MedPage Today here.

Leave a Comment

Your email address will not be published.